CDEK
← All organizations
Insmed, Inc.

Insmed, Inc.

For profitWebsite ↗

Also known as: Imsmed Incorporated | INSMED | Insmed Gene Therapy LLC | INSMED INC | Insmed Incorporated

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 12, 2004

First marketed drug

Dec 12, 2005

Last known activity

Apr 1, 2026

Acquired by Merck on Jan 1, 2009

Timeline

1980s

  1. Jun 1, 1988

    Insmed, Inc.— Founded

2000s

  1. Jan 1, 2009

    Merck— Acquired By

2010s

  1. Dec 2, 2010

    Transave Inc.— Acquired

  2. Sep 28, 2018

    amikacin— NDA Secondary Org

2020s

  1. Aug 12, 2025

    brensocatib— Marketing Organization

Drugs by trial phase (20 distinct, 49 trials)

Indications

Studied for

Marketed drugs (3)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Bridgewater Township, NJ, US Jun 1, 1988
Last known activity
Apr 1, 2026